National Research Corporation (NRC) at a glance

National Research Corporation (NRC) is a small-cap Healthcare company. It trades at $22.04, with a P/E of 48.2, a 6.5% profit margin and revenue growth of 3.7%. It pays a 3.2% dividend yield. Vestovix scores it 44/100 overall. Its strongest dimension is Safety (80/100) and its weakest is Value (14/100). It is a relatively defensive holding with below-market volatility.

Price
$22.04
Market cap
$423.5M
P/E ratio
48.2
Dividend yield
3.23%
Beta
0.40
52-week range
$11.01 to $23.68
Vestovix Score44/ 100How this works
Value
14
Growth
28
Income
49
Safety
80
Momentum
77

Other Healthcare stocks

See all